Xavier L.
- Country
- France
- Department
- Radiotherapist
Research Overview
- Evaluation of Lymphocyte-Sparing Radiotherapy and All-Trans Retinoic Acid in Lateralized Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Carcinoma
- Phase II Study of JNJ-90301900 in Combination with Concurrent Chemoradiotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
- Pan-lesions SBRT combined with lymphocyte support through ATRA-driven blockade of MDSC in patients with oligometastatic solid cancer (LySATRA)
Data & Insights
Has run more than one trial at 23 of 118 partner sites.
Specializations
Head and Neck Oncology
This investigator specializes in treating various forms of head and neck cancers, with particular emphasis on squamous cell carcinoma affecting different anatomical regions including the oropharynx, larynx, and hypopharynx.
- Salivary Gland Tumors
- Sinus Malignancies
- Oropharyngeal Cancer
- Laryngeal Cancer
The investigator has extensive experience in managing both resectable and non-operable cases.
Therapeutic Approaches
The investigator focuses on developing innovative treatment combinations incorporating radiotherapy with various therapeutic agents.
- Combined Modality Treatment
- Chemoradiotherapy
- Immunotherapy Combinations
- Novel Agent Integration
Particular attention is given to tailored radiation approaches and targeted volume treatments.
Clinical Innovation
The investigator explores treatment optimization for specific patient populations, including elderly patients and those ineligible for conventional therapies.
- Lymphocyte-Sparing Techniques
- Radio-Immunotherapy
- Adjuvant Therapy
- Survival Outcomes
Research focuses on improving disease-free and locoregional event-free survival rates.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.